[HTML][HTML] Expression of HLA class I and HLA class II by tumor cells in Chinese classical Hodgkin lymphoma patients
X Huang, A van den Berg, Z Gao, L Visser, I Nolte… - PLoS …, 2010 - journals.plos.org
X Huang, A van den Berg, Z Gao, L Visser, I Nolte, H Vos, B Hepkema, W Kooistra…
PLoS One, 2010•journals.plos.orgBackground In Caucasian populations, the tumor cells of Epstein Barr virus (EBV)-positive
classical Hodgkin Lymphomas (cHL) patients more frequently express HLA class I and HLA
class II molecules compared to EBV-negative cHL patients. HLA expression (in relation to
EBV) in Asian cHL patients has not been previously investigated. Methodology/Principal
Findings We randomly selected 145 cHL patients with formalin-fixed, paraffin embedded
tissue blocks available from 5 hospitals from the Northern part of China. Hematoxylin & …
classical Hodgkin Lymphomas (cHL) patients more frequently express HLA class I and HLA
class II molecules compared to EBV-negative cHL patients. HLA expression (in relation to
EBV) in Asian cHL patients has not been previously investigated. Methodology/Principal
Findings We randomly selected 145 cHL patients with formalin-fixed, paraffin embedded
tissue blocks available from 5 hospitals from the Northern part of China. Hematoxylin & …
Background
In Caucasian populations, the tumor cells of Epstein Barr virus (EBV)-positive classical Hodgkin Lymphomas (cHL) patients more frequently express HLA class I and HLA class II molecules compared to EBV-negative cHL patients. HLA expression (in relation to EBV) in Asian cHL patients has not been previously investigated.
Methodology/Principal Findings
We randomly selected 145 cHL patients with formalin-fixed, paraffin embedded tissue blocks available from 5 hospitals from the Northern part of China. Hematoxylin & Eosin-stained slides were used to reclassify the histological subtypes according to the WHO classification. EBV status was determined by visualization of EBERs in tumor cells using in situ hybridization. Membranous expression of HLA molecules was detected by immunohistochemistry using antibodies HC-10 (class I heavy chain) and anti-ß2-microglobulin for HLA class I, and CR3/43 for HLA class II. EBV+ tumor cells were observed in 40% (58/145) of the cHL patients. As expected, the percentage of EBV+ cases was much higher in the mixed cellularity subtype (71%) than in the nodular sclerosis subtype (16%) (p<0.001). Expression of HLA class I was observed in 79% of the EBV+ cHL cases and in 30% of the EBV- cases (p<0.001). For HLA class II, 52% of EBV+ cHL cases were positive, compared to 43% in EBV- cases (p = 0.28).
Conclusions
The results in the Northern China population were similar to those in the Caucasian population for HLA class I, but not for HLA class II.
![](/scholar/images/qa_favicons/plos.org.png)
以上显示的是最相近的搜索结果。 查看全部搜索结果